ESRRA and prostate carcinoma: Conditioned media experiments using prostate cancer cells with inducible expression of PGC1α and CRISPR-CAS9-induced deletion of ERRα ([11]; Supplementary Fig. 2A, B) showed that loss of ERRα in producer cells prevented the paracrine action of PGC1α in recipient cells (Fig. 2A).